Main useThe subcutaneous products on this page are mainly used for plaque psoriasis and psoriatic arthritis.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- スキリージ皮下注55mg／75mg／150mg シリンジ・150mgペン
- Brand
- Skyrizi
- Generic name
- Risankizumab
- Japanese generic name
- リサンキズマブ
- Chinese name
- 利生奇珠单抗
- Marketing authorization holder
- アッヴィ合同会社
- Strengths
- 55 mg / 75 mg / 150 mg
- Dosage form
- SC syringe / pen
- Therapeutic area
- Immunologie
- Regulatory status
- Rx
- Label updated
- 2026-09-16
- TOKYO MEDI verified
- 2026-09-22
Offizielle Quelle
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.